These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27313194)

  • 1. Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor.
    Holst JJ; Madsbad S
    Surg Obes Relat Dis; 2016 Jul; 12(6):1236-42. PubMed ID: 27313194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.
    Salehi M; D'Alessio DA
    Surg Obes Relat Dis; 2016 Jul; 12(6):1230-5. PubMed ID: 27568473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
    Smith EP; Polanco G; Yaqub A; Salehi M
    Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in weight loss surgery and gastrointestinal peptides.
    Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
    Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
    Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Dirksen C; Svane M
    Peptides; 2024 Jun; 176():171199. PubMed ID: 38552903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
    Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
    Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 is not the key mediator of the health benefits of metabolic surgery.
    Vidal J; de Hollanda A; Jiménez A
    Surg Obes Relat Dis; 2016 Jul; 12(6):1225-9. PubMed ID: 27313195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
    Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
    Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
    J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
    Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
    EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.